<DOC>
	<DOCNO>NCT00006208</DOCNO>
	<brief_summary>The purpose study compare safety effectiveness emtricitabine stavudine give didanosine plus efavirenz HIV-infected patient .</brief_summary>
	<brief_title>A Comparison Emtricitabine Stavudine Used With Didanosine Plus Efavirenz HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Stavudine</mesh_term>
	<mesh_term>Didanosine</mesh_term>
	<mesh_term>Efavirenz</mesh_term>
	<mesh_term>Emtricitabine</mesh_term>
	<criteria>Inclusion Criteria Patients may eligible study : Are least 18 year old time screening . Have plasma HIV1 RNA load ( level HIV blood ) 5,000 copies/ml time screen . Have use antiHIV therapy 2 day . Have negative pregnancy test within 22 day start study drug . Can reach telephone . Exclusion Criteria Patients eligible study : Are pregnant breastfeeding . Use alcohol illegal drug , opinion principal investigator , may interfere patient 's ability follow dose schedule protocol evaluation . Are treat active tuberculosis . Are use astemizole , cisapride , midazolam , triazolam , ergot derivative , St. John 's wort , drug mental disorder . Have history serious mental disorder . Are unwilling use effective barrier method birth control study ( woman get pregnant ) . Have history opportunistic infection cancer ( Mycobacterium avium complex , cytomegalovirus , toxoplasmic encephalitis disseminate toxoplasmosis , cryptosporidiosis , Isospora belli , progressive multifocal leukoencephalopathy , visceral Kaposi 's sarcoma , lymphoma ) . Patients past episode pulmonary tuberculosis , Pneumocystis carinii pneumonia , isolate cutaneous Kaposi 's sarcoma allow . Medication prevention PCP ( TMP/SMX , nebulized pentamidine , atovaquone ) allow . Have peripheral neuropathy ( painful condition affect nervous system ) history peripheral neuropathy . Can take medicine mouth severe chronic diarrhea within 30 day begin study . Can eat 1 meal day chronic nausea , vomit , abdominal esophageal discomfort . Have serious illness injury within 30 day screen . Treatment must complete 14 day prior study entry . Have history AIDSdefining opportunistic infection , except tuberculosis infection stomach intestine .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2006</verification_date>
	<keyword>HIV-1</keyword>
	<keyword>Didanosine</keyword>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Reverse Transcriptase Inhibitors</keyword>
	<keyword>Anti-HIV Agents</keyword>
	<keyword>Deoxycytidine</keyword>
	<keyword>efavirenz</keyword>
</DOC>